Biomarkers and surrogate endpoints in randomized clinical trials

QR Code

Biomarkers and surrogate endpoints in randomized clinical trials

Show other versions (2)

Saved in:

Bibliographic Details
Other Authors:	Buyse, Marc E. (Speaker)
Format:	Electronic Video
Language:	English
Published:	London : Henry Stewart Talks, 2016.
Series:	Henry Stewart talks. Biomedical & life sciences collection. Design and analysis of randomized clinical trials : design, analysis & theory.
Subjects:	Antineoplastic agents > Testing. Biochemical markers. Clinical trials > Statistical methods. Research > Design. Tumor markers. Antineoplastic Agents > therapeutic use. Biomarkers, Tumor. Biometry > methods. Neoplasms > drug therapy. Prognosis. Randomized Controlled Trials as Topic > statistics & numerical data. Research Design.
Online Access:	https://hstalks.com/bs/554/ Series
Tags:	Add Tag No Tags, Be the first to tag this record!

Table of Contents:

Contents: Definitions (prognostic biomarker, predictive biomarker, surrogate endpoint)
Statistical validation of biomarkers
Examples of surrogate endpoints in oncology.